The microRNA-27a: ZBTB10-specificity protein pathway is involved in follicle stimulating hormone-induced VEGF, Cox2 and survivin expression in ovarian epithelial cancer cells

International Journal of Oncology

Volumn 42, Issue 2, 2013, Pages 776-784

  Lai, Yunli ^a,b,c   Zhang, Xuerong ^c   Zhang, Zhenbo ^a   Shu, Yuyan ^c   Luo, Xiaoling ^c   Yang, Yongbin ^a   Wang, Xiaojie ^a   Yang, Guoping ^a   Li, Linxia ^a   Feng, Youji ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Guangxi Matemal and Child Health Hospital   (China)

^c GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Follicle stimulating hormone; MicroRNA 27a; Ovarian epithelial cancer; VEGF

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLOOXYGENASE 2; FOLLITROPIN; MICRORNA; MICRORNA 27A; PROTEIN; SMALL INTERFERING RNA; SURVIVIN; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; VASCULOTROPIN; ZBTB 10 SPECIFICITY PROTEIN;

ANGIOGENESIS; ANTISENSE THERAPY; ARTICLE; CANCER CELL; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE 2; DOWN-REGULATION; FEMALE; FOLLICLE STIMULATING HORMONE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICRORNAS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84873662798     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1743     Document Type: Article

References (38)

1. Choi JH, Wong AS, Huang HF and Leung PC: Gonadotropins and ovarian cancer. Endocr Rev 28: 440-461, 2007.
2. Choi KC, Kang SK, Tai CJ, Auersperg N and Leung PC: Follicle stimulating hormone activates mitogen-activated protein kinase in preneoplastic and neoplastic ovarian surface epithelial cells. J Clin Endocrinol Metab 87: 2245-2253, 2002.
3. Huang Y, Jin H, Liu Y, et al: FSH inhibits ovarian cancer cell apoptosis by up-regulating survivin and down-regulating PDCD6 and DR5. Endocr Relat Cancer 18: 13-26, 2010.
4. Huang Y, Hua K, Zhou X, et al: Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma. Cell Res 18: 780-791, 2008.
5. Ryan BM, Konecny GE, Kahlert S, et al: Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1. Ann Oncol 17: 597-604, 2006.
6. Cai X, Ma S, Gu M, Zu C, Qu W and Zheng X: Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancer. Diagn Pathol 7: 52, 2012.
7. Mertens-Talcott SU, Chintharlapalli S, Li X and Safe S: The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res 67: 11001-11011, 2007.
8. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
9. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
10. Gagan J, Dey BK, Layer R, Yan Z and Dutta A: MicroRNA-378 targets the myogenic repressor MyoR during myoblast differentiation. J Biol Chem 286: 19431-19438, 2011.
11. Kloosterman WP and Plasterk RH: The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450, 2006.
12. Naguibneva I, Ameyar-Zazoua M, Polesskaya A, et al: The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat Cell Biol 8: 278-284, 2006.
13. Sugatani T and Hruska KA: MicroRNA-223 is a key factor in osteoclast differentiation. J Cell Biochem 101: 996-999, 2007.
14. Nishi H, Ono K, Horie T, et al: MicroRNA-27a regulates beta cardiac myosin heavy chain gene expression by targeting thyroid hormone receptor beta1 in neonatal rat ventricular myocytes. Mol Cell Biol 31: 744-755, 2011.
15. Li X, Mertens-Talcott SU, Zhang S, Kim K, Ball J and Safe S: MicroRNA-27a indirectly regulates estrogen receptor {alpha} expression and hormone responsiveness in MCF-7 breast cancer cells. Endocrinology 151: 2462-2473, 2010.
16. Wang J, Luo F, Lu JJ, Chen PK, Liu P and Zheng W: VEGF expression and enhanced production by gonadotropins in ovarian epithelial tumors. Int J Cancer 97: 163-167, 2002.
17. Liao H, Zhou Q, Gu Y, Duan T and Feng Y: Luteinizing hormone facilitates angiogenesis in ovarian epithelial tumor cells and metformin inhibits the effect through the mTOR signaling pathway. Oncol Rep 27: 1873 1878, 2012.
18. Wong C, Wellman TL and Lounsbury KM: VEGF and HIF-1alpha expression are increased in advanced stages of epithelial ovarian cancer. Gynecol Oncol 91: 513-517, 2003.
19. Gallo O, Franchi A, Magnelli L, et al: Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Neoplasia 3: 53-61, 2001.
20. Kim MH, Seo SS, Song YS, et al: Expression of cyclooxygenase-1 and -2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes. Gynecol Oncol 90: 83-90, 2003.
21. Marrogi AJ, Travis WD, Welsh JA, et al: Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin Cancer Res 6: 4739-4744, 2000.
22. Shtivelband MI, Juneja HS, Lee S and Wu KK: Aspirin and salicylate inhibit colon cancer medium- and VEGF-induced endothelial tube formation: correlation with suppression of cyclooxygenase-2 expression. J Thromb Haemost 1: 2225-2233, 2003.
23. Zhang J, Ji J, Yuan F, et al: Cyclooxygenase-2 expression is associated with VEGF-C and lymph node metastases in gastric cancer patients. Biomed Pharmacother 59 (Suppl 2): S285-S288, 2005.
24. Li ZM, Hu S, Xiao L, et al: Expression of microRNA 27a and its correlation with drug resistance in human ovarian cancer A2780/Taxol cells. Zhonghua Fu Chan Ke Za Zhi 45: 372-375, 2010 (In Chinese).
25. Chintharlapalli S, Papineni S, Abdelrahim M, et al: Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3, 11-dioxo-18beta-olean-1, 12-dien-30-oate in colon cancer cells. Int J Cancer 125: 1965-1974, 2009.
26. Philipsen S and Suske G: A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res 27: 2991-3000, 1999.
27. Bouwman P and Philipsen S: Regulation of the activity of Sp1-related transcription factors. Mol Cell Endocrinol 195: 27-38, 2002.
28. Safe S and Abdelrahim M: Sp transcription factor family and its role in cancer. Eur J Cancer 41: 2438-2448, 2005.
29. Lou Z, O'Reilly S, Liang H, Maher VM, Sleight SD and McCormick JJ: Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation. Cancer Res 65: 1007-1017, 2005.
30. Wang L, Wei D, Huang S, et al: Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res 9: 6371-6380, 2003.
31. Zhang J, Zhu ZG, Ji J, et al: Transcription factor Sp1 expression in gastric cancer and its relationship to long-term prognosis. World J Gastroenterol 11: 2213-2217, 2005.
32. Yao JC, Wang L, Wei D, et al: Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer. Clin Cancer Res 10: 4109-4117, 2004.
33. Akiyama H, Tanaka T, Maeno T, et al: Induction of VEGF gene expression by retinoic acid through Sp1-binding sites in retinoblastoma Y79 cells. Invest Ophthalmol Vis Sci 43: 1367-1374, 2002.
34. Bermudez Y, Yang H, Saunders BO, Cheng JQ, Nicosia SV and Kruk PA: VEGF- and LPA-induced telomerase in human ovarian cancer cells is Sp1-dependent. Gynecol Oncol 106: 526-537, 2007.
35. Cho SG, Yi Z, Pang X, et al: Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation. Cancer Res 69: 7062-7070, 2009.
36. Li ZY, Zhu F, Hu JL, et al: Sp1 inhibition-mediated upregulation of VEGF 165 b induced by rh-endostatin enhances antiangiogenic and anticancer effect of rh-endostatin in A549. Tumour Biol 32: 677-687, 2011.
37. Loeffler S, Fayard B, Weis J and Weissenberger J: Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1. Int J Cancer 115: 202-213, 2005.
38. Novak EM, Metzger M, Chammas R, et al: Downregulation of TNF-alpha and VEGF expression by Sp1 decoy oligodeoxynucleotides in mouse melanoma tumor. Gene Ther 10: 1992-1997, 2003.